SNWV — SANUWAVE Health Income Statement
0.000.00%
- $20.17m
- $46.15m
- $20.40m
- 40
- 81
- 44
- 55
Annual income statement for SANUWAVE Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.03 | 4.06 | 13 | 16.7 | 20.4 |
Cost of Revenue | |||||
Gross Profit | 0.49 | 2.9 | 8.02 | 12.4 | 14.4 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 9.82 | 29.8 | 30.5 | 29.5 | 20.9 |
Operating Profit | -8.79 | -25.8 | -17.5 | -12.8 | -0.54 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -10.4 | -30.9 | -27.2 | -10.3 | -25.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -10.4 | -30.9 | -27.3 | -10.3 | -25.8 |
Net Income Before Extraordinary Items | |||||
Net Income | -10.4 | -30.9 | -27.3 | -10.3 | -25.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -10.4 | -30.9 | -27.3 | -10.3 | -25.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.051 | -0.058 | -0.048 | -0.014 | -0.033 |